309 related articles for article (PubMed ID: 9163651)
1. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.
Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W
Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhaled prostacyclin as compared with inhaled nitric oxide in a canine model of pulmonary microembolism and oleic acid edema.
Zwissler B; Welte M; Habler O; Kleen M; Messmer K
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):634-40. PubMed ID: 8664452
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs.
Welte M; Zwissler B; Habler O; Kleen M; Messmer K
Acta Physiol Scand; 1995 Jul; 154(3):395-405. PubMed ID: 7572237
[TBL] [Abstract][Full Text] [Related]
4. Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Schudt C; Tenor H; Grimminger F; Seeger W; Walmrath D
J Pharmacol Exp Ther; 2000 Feb; 292(2):512-20. PubMed ID: 10640287
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of inhaled prostanoids in experimental pulmonary hypertension.
Kleen M; Habler O; Hofstetter C; Pusch R; Mueller M; Welte M; Zwissler B
Crit Care Med; 1998 Jun; 26(6):1103-9. PubMed ID: 9635662
[TBL] [Abstract][Full Text] [Related]
6. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
7. Inhaled nitric oxide does not alter the longitudinal distribution of pulmonary vascular resistance.
Lindeborg DM; Kavanagh BP; Van Meurs K; Pearl RG
J Appl Physiol (1985); 1995 Jan; 78(1):341-8. PubMed ID: 7713835
[TBL] [Abstract][Full Text] [Related]
8. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
Meyer J; Theilmeier G; Van Aken H; Bone HG; Busse H; Waurick R; Hinder F; Booke M
Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
[TBL] [Abstract][Full Text] [Related]
9. Zardaverine and aerosolised iloprost in a model of acute respiratory failure.
Schermuly RT; Leuchte H; Ghofrani HA; Weissmann N; Rose F; Kohstall M; Olschewski H; Schudt C; Grimminger F; Seeger W; Walmrath D
Eur Respir J; 2003 Aug; 22(2):342-7. PubMed ID: 12952271
[TBL] [Abstract][Full Text] [Related]
10. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B
Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
[TBL] [Abstract][Full Text] [Related]
12. Site of pulmonary vasodilation by inhaled nitric oxide in the perfused lung.
Rimar S; Gillis CN
J Appl Physiol (1985); 1995 May; 78(5):1745-9. PubMed ID: 7649908
[TBL] [Abstract][Full Text] [Related]
13. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
14. PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction.
Welte M; Zwissler B; Habazettl H; Messmer K
Eur Surg Res; 1993; 25(5):329-40. PubMed ID: 8404993
[TBL] [Abstract][Full Text] [Related]
15. Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension.
Patterson KW; Deb B; Kavanagh BP; Pearl RG
Pharmacology; 1999 May; 58(5):246-51. PubMed ID: 10087465
[TBL] [Abstract][Full Text] [Related]
16. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
17. Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome.
Putensen C; Hörmann C; Kleinsasser A; Putensen-Himmer G
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1743-7. PubMed ID: 9620900
[TBL] [Abstract][Full Text] [Related]
18. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.
Walmrath D; Schneider T; Schermuly R; Olschewski H; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1996 Mar; 153(3):991-6. PubMed ID: 8630585
[TBL] [Abstract][Full Text] [Related]
19. Protection against gas exchange abnormalities by pre-aerosolized PGE1, iloprost and nitroprusside in lung ischemia-reperfusion.
Löckinger A; Schütte H; Walmrath D; Seeger W; Grimminger F
Transplantation; 2001 Jan; 71(2):185-93. PubMed ID: 11213057
[TBL] [Abstract][Full Text] [Related]
20. [Inhalative strategies for improvement of pulmonary hemodynamics and gas exchange in sepsis and severe pulmonary hypertension].
Grimminger F; Rose F; Ghofrani HA; Schermuly RT; Weissmann N; Olschewski H; Walmrath D; Seeger W
Z Kardiol; 2000 Jun; 89(6):477-84. PubMed ID: 10929431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
